Tandem Diabetes Care, Inc. (TNDM) is a publicly traded Healthcare sector company. As of November 12, 2026, TNDM trades at $19.06 with a market cap of $1.31B and a P/E ratio of -17.90. TNDM moved +1.52% today. Year to date, TNDM is -18.95%; over the trailing twelve months it is +7.09%. Its 52-week range spans $9.98 to $29.65. Analyst consensus is buy with an average price target of $27.82. Rallies surfaces TNDM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for TNDM, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $19.06 |
| Market Cap | $1.31B |
| P/E Ratio | -17.90 |
| EPS | $-0.92 |
| Dividend Yield | 0.00% |
| 52-Week High | $29.65 |
| 52-Week Low | $9.98 |
| Volume | 9.73K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.04B |
| Net Income | $-63.31M |
| Gross Margin | 56.01% |
13 analysts cover TNDM: 0 strong buy, 8 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $27.82.